We have located links that may give you full text access.
Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser.
British Journal of Ophthalmology 1998 November
BACKGROUND/AIMS: In the management of retinopathy of prematurity (ROP), several studies have demonstrated laser photocoagulation to be as effective as cryotherapy in reducing the incidence of unfavourable structural outcome. However, few data are available on the functional outcome. The 3 year visual acuity outcome of infants treated with laser or cryotherapy in a neonatal unit is presented.
METHODS: The case notes of 34 infants (64 eyes) treated with cryotherapy, between 1989 and 1992, and 32 infants (59 eyes) treated with laser, between 1992 and 1995, were reviewed.
RESULTS: In the cryotherapy group 69% of eyes had a favourable structural outcome. Of these structurally successful eyes 62.5%, 35.0%, and 33.3% of eyes had visual acuities within normal limits at the 12 month, 24 month, and 36 month corrected age milestones respectively. In the laser group 93% of eyes had a favourable structural outcome. Of these structurally successful eyes 96.4%, 66.7%, and 59.5% of eyes had visual acuities within normal limits at the 12 month, 24 month, and 36 month corrected age milestones respectively.
CONCLUSION: In the management of ROP, when laser photocoagulation induces a structurally successful result, the potential for normal visual acuity development at 3 years is high. Whether the poorer functional outcome of the eyes treated with cryotherapy is an artefact of the historical nature of the study or as a result of an adverse effect of the destructive transcleral application is unknown.
METHODS: The case notes of 34 infants (64 eyes) treated with cryotherapy, between 1989 and 1992, and 32 infants (59 eyes) treated with laser, between 1992 and 1995, were reviewed.
RESULTS: In the cryotherapy group 69% of eyes had a favourable structural outcome. Of these structurally successful eyes 62.5%, 35.0%, and 33.3% of eyes had visual acuities within normal limits at the 12 month, 24 month, and 36 month corrected age milestones respectively. In the laser group 93% of eyes had a favourable structural outcome. Of these structurally successful eyes 96.4%, 66.7%, and 59.5% of eyes had visual acuities within normal limits at the 12 month, 24 month, and 36 month corrected age milestones respectively.
CONCLUSION: In the management of ROP, when laser photocoagulation induces a structurally successful result, the potential for normal visual acuity development at 3 years is high. Whether the poorer functional outcome of the eyes treated with cryotherapy is an artefact of the historical nature of the study or as a result of an adverse effect of the destructive transcleral application is unknown.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app